American Funds EUPAC F-2 (AEPFX)

Nasdaq • Currently up 0.01 (+0.02%) in today's trading session

3 members of Congress have disclosed 7 trades in American Funds EUPAC F-2 (AEPFX) via STOCK Act filings. The most recent disclosure was a sale by Nathaniel Moran on 31 July 2023. The most active traders have been Nathaniel Moran (3), Mary Gay Scanlon (2), and Lisa Blunt Rochester (2). Aggregate disclosed activity totals roughly $64.5K in purchases and $40.5K in sales (midpoint estimates from bracketed disclosure amounts).

American Funds EUPAC F-2 is currently trading at $65.31, positioned at 77% of its 52-week range ($57.05 – $67.76).

Want to automatically copy Pelosi trades?

Mirror Nancy Pelosi's portfolio with just one click on eToro.

Claim Free AssetCopy Portfolio

Copy Trading does not amount to investment advice. The value of your investments may go up or down. Your capital is at risk.

Past Performance is not an indication of future results.

Current Price
$65.31
24h Change
+0.01 (+0.02%)
52 Week Range
$57.05—$67.76
View on NASDAQ

American Funds EUPAC F-2 Price History and Technical Analysis

Interactive Chart

Congressional Trading Activity for AEPFX

Select to highlight on chart
0 transactions
Compliance: 0%
No data

Select transactions to view their annotations on the chart

Stock Overview

Market Data

Market Cap

$144.31B

Volume

0

Beta

0.90

P/E Ratio

19.94

Fundamentals

EPS

$3.27

Div. Yield

16.01%

Open

$65.31

Day Range

$65.31 — $65.31

Company Information

Sector
Financial Services
Industry
Asset Management
Exchange
NASDAQ · USD
Country
US
IPO Date
2008-08-01
Website
www.capitalgroup.com

This investment vehicle primarily seeks to acquire common shares from companies operating within Europe and the Pacific Rim. The fund's advisor targets businesses in these regions that they believe demonstrate robust potential for expansion. These "g...

No earnings data available for this stock.

Dividends

Dividend History

15 Jun 2026
Amount $3.7165
18 Dec 2025
Amount $6.7369
9 Jun 2025
Amount $1.6642
19 Dec 2024
Amount $2.3598
10 Jun 2024
Amount $1.3772
14 Dec 2023
Amount $1.9100
12 Jun 2023
Amount $0.1946
15 Dec 2022
Amount $0.6765
13 Jun 2022
Amount $0.2677
16 Dec 2021
Amount $3.4328
14 Jun 2021
Amount $3.0906
17 Dec 2020
Amount $0.2330
19 Dec 2019
Amount $1.6166
12 Jun 2019
Amount $0.0673
20 Dec 2018
Amount $1.3345
13 Jun 2018
Amount $1.6593
21 Dec 2017
Amount $1.6272
14 Jun 2017
Amount $1.1149
22 Dec 2016
Amount $0.6929
23 Dec 2015
Amount $1.5138
26 Dec 2014
Amount $0.7887
26 Dec 2013
Amount $0.5745
26 Dec 2012
Amount $0.8164
27 Dec 2011
Amount $0.6993
28 Dec 2010
Amount $0.6769
29 Dec 2009
Amount $0.7278
23 Dec 2008
Amount $2.2072

No stock split data available for this stock.

Similar Stocks

Based on congressional trading patterns

Smart Recommendations
No similar stocks found
No congressional trading patterns available for recommendations

Frequently Asked Questions about AEPFX

Which members of Congress have traded AEPFX?
3 members of Congress have disclosed 7 trades in American Funds EUPAC F-2 (AEPFX) under the STOCK Act. The most active traders are Nathaniel Moran, Mary Gay Scanlon, and Lisa Blunt Rochester.
When was AEPFX most recently disclosed by Congress?
The most recent AEPFX disclosure was a sale by Nathaniel Moran on 31 July 2023.
What is the total disclosed congressional trading volume for AEPFX?
Members of Congress have disclosed approximately $64.5K in AEPFX purchases and $40.5K in sales. These figures are midpoint estimates derived from the bracketed amount ranges used in STOCK Act filings.
How can I track new congressional trades in AEPFX?
This AEPFX page updates as soon as new STOCK Act disclosures are filed for American Funds EUPAC F-2. Every trade, politician, transaction date and amount range is surfaced above, typically within hours of the official filing appearing on the House or Senate disclosure portals.
Pelosi Tracker
PoliticiansBillsArticlesPortfoliosPricingAboutLegalTerms of ServicePrivacy Policy
Français
© 2026 - All rights reserved. Powered by Vantara Labs
Pelosi Tracker is an independent, third-party platform. It is not affiliated with, endorsed by, or in any way associated with Nancy Pelosi, her office or her representatives, or with any other member of Congress. Any use of her name is solely for the purpose of discussing publicly available information.The information provided by Pelosi Tracker is for informational and educational purposes only and is not intended to serve as, nor should it be construed as, financial or investment advice. The data presented here is sourced from publicly available filings and records. While we strive for accuracy, timeliness, and completeness, we do not guarantee that all information is error-free or current.